{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:59:52Z","timestamp":1781603992221,"version":"3.54.5"},"reference-count":47,"publisher":"American Diabetes Association","issue":"12","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,12,1]]},"abstract":"<jats:p>This study assessed whether painful diabetic neuropathy is associated with abnormal sympathetic nervous function in the affected limbs. Nine patients with diabetes (four men, five women; age 61 \u00b1 7 years) and painful peripheral neuropathy of the feet, but without evidence of generalized autonomic neuropathy, underwent intravenous infusion of tritiated norepinephrine (NE) and sampling of arterial and venous blood in both feet and in one arm to quantify the rate of entry of NE into the local venous plasma (NE spillover). In the same patients, positron emission tomography (PET) scanning after intravenous injection of the sympathoneural imaging agent 6-[18F]fluorodopamine was used to visualize sympathetic innervation and after intravenous [13N]ammonia to visualize local perfusion. The results were compared with those in the feet of normal volunteers and in an unaffected foot of patients with unilateral complex regional pain syndrome (CRPS). In addition, neurochemical results obtained in painful diabetic neuropathy were compared with those obtained in diabetic control patients with painless neuropathy and diabetic control patients without neuropathy. Local arteriovenous difference in plasma NE levels (\u0394NEAV) and NE spillover in the arms did not differ across the groups. However, \u0394NEAV in the feet was significantly less in the group with painful diabetic neuropathy than in the control groups. Also NE spillover in the feet tended to be lower in painful neuropathy. \u0394NEAV of diabetic control patients without neuropathy (n = 6) resembled values in the control groups without diabetes, whereas patients with painless diabetic neuropathy (n = 6) had evidence suggesting partial loss of sympathetic innervation. PET scanning revealed decreased flow-corrected 6-[18F]fluorodopamine-derived radioactivity in patients with painful diabetic neuropathy, compared with values in normal volunteers and patients with CRPS. The results provide neurochemical and neuroimaging evidence for regionally selective sympathetic denervation in the painful feet of patients with diabetic neuropathy.<\/jats:p>","DOI":"10.2337\/diabetes.51.12.3545","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"3545-3553","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":36,"title":["Local Sympathetic Denervation in Painful Diabetic Neuropathy"],"prefix":"10.2337","volume":"51","author":[{"given":"Cees J.","family":"Tack","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra J.","family":"van Gurp","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University Medical Center Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Holmes","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031223250228000_R1","doi-asserted-by":"crossref","unstructured":"Boulton AJ, Malik RA: Diabetic neuropathy. Med Clin North Am\u200882:909\u2013929,1998","DOI":"10.1016\/S0025-7125(05)70029-8"},{"key":"2022031223250228000_R2","doi-asserted-by":"crossref","unstructured":"Ertas M, Sagduyu A, Arac N, Uludag B, Ertekin C: Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain\u200875:257\u2013259,1998","DOI":"10.1016\/S0304-3959(98)00003-7"},{"key":"2022031223250228000_R3","doi-asserted-by":"crossref","unstructured":"Britland ST, Young RJ, Sharma AK, Clarke BF: Acute and remitting painful diabetic polyneuropathy: a comparison of peripheral nerve fibre pathology. Pain\u200848:361\u2013370,1992","DOI":"10.1016\/0304-3959(92)90085-P"},{"key":"2022031223250228000_R4","doi-asserted-by":"crossref","unstructured":"Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R: Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology\u200837:589\u2013596,1987","DOI":"10.1212\/WNL.37.4.589"},{"key":"2022031223250228000_R5","doi-asserted-by":"crossref","unstructured":"Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R: Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med\u2008326:1250\u20131256,1992","DOI":"10.1056\/NEJM199205073261904"},{"key":"2022031223250228000_R6","doi-asserted-by":"crossref","unstructured":"Byas Smith MG, Max MB, Muir J, Kingman A: Transdermal clonidine compared to placebo in painful diabetic neuropathy using a two-stage \u2018enriched enrollment\u2019 design. Pain\u200860:267\u2013274,1995","DOI":"10.1016\/0304-3959(94)00121-T"},{"key":"2022031223250228000_R7","doi-asserted-by":"crossref","unstructured":"Tsigos C, Reed P, Weinkove C, White A, Young RJ: Plasma norepinephrine in sensory diabetic polyneuropathy. Diabetes Care\u200816:722\u2013727,1993","DOI":"10.2337\/diacare.16.5.722"},{"key":"2022031223250228000_R8","doi-asserted-by":"crossref","unstructured":"Ghostine SY, Comair YG, Turner DM, Kassell NF, Azar CG: Phenoxybenzamine in the treatment of causalgia: report of 40 cases. J Neurosurg\u200860:1263\u20131268,1984","DOI":"10.3171\/jns.1984.60.6.1263"},{"key":"2022031223250228000_R9","doi-asserted-by":"crossref","unstructured":"Walker SM, Cousins MJ: Complex regional pain syndromes: including \u201creflex sympathetic dystrophy\u201d and \u201ccausalgia.\u201d Anaesth Intensive Care\u200825:113\u2013125,1997","DOI":"10.1177\/0310057X9702500202"},{"key":"2022031223250228000_R10","doi-asserted-by":"crossref","unstructured":"Birklein F, Riedl B, Claus D, Neundorfer B: Pattern of autonomic dysfunction in time course of complex regional pain syndrome. Clin Auton Res\u20088:79\u201385,1998","DOI":"10.1007\/BF02267817"},{"key":"2022031223250228000_R11","doi-asserted-by":"crossref","unstructured":"Boulton AJ, Scarpello JH, Ward JD: Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting?Diabetologia\u200822:6\u20138,1982","DOI":"10.1007\/BF00253861"},{"key":"2022031223250228000_R12","doi-asserted-by":"crossref","unstructured":"Flynn MD, Tooke JE: Diabetic neuropathy and the microcirculation. Diabet Med\u200812:298\u2013301,1995","DOI":"10.1111\/j.1464-5491.1995.tb00480.x"},{"key":"2022031223250228000_R13","doi-asserted-by":"crossref","unstructured":"Purewal TS, Watkins PJ: Postural hypotension in diabetic autonomic neuropathy: a review. Diabet Med\u200812:192\u2013200,1995","DOI":"10.1111\/j.1464-5491.1995.tb00458.x"},{"key":"2022031223250228000_R14","doi-asserted-by":"crossref","unstructured":"Esler M: Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses. Pharmacol Toxicol\u200873:243\u2013253,1993","DOI":"10.1111\/j.1600-0773.1993.tb00579.x"},{"key":"2022031223250228000_R15","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Eisenhofer G, Stull R, Folio CJ, Keiser HR, Kopin IJ: Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest\u200881:213\u2013220,1988","DOI":"10.1172\/JCI113298"},{"key":"2022031223250228000_R16","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Brush JE, Cannon RO 3d, Stull R, Kopin IJ, Goldstein DS: Plasma dihydroxyphenylalanine and total body and regional noradrenergic activity in humans. J Clin Endocrinol Metab\u200868:247\u2013255,1989","DOI":"10.1210\/jcem-68-2-247"},{"key":"2022031223250228000_R17","doi-asserted-by":"crossref","unstructured":"Endo M, Yoshida K, Iinuma TA, Yamasaki T, Tateno Y, Masuda Y, Inagaki Y: Noninvasive quantification of regional myocardial blood flow and ammonia extraction fraction using nitrogen-13 ammonia and positron emission tomography. Ann Nucl Med\u20081:1\u20136,1987","DOI":"10.1007\/BF03164543"},{"key":"2022031223250228000_R18","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Stuhlmuller JE, Lenders JWM, Kopin IJ: 6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function: studies in normal humans. Clin Auton Res\u20087:17\u201329,1997","DOI":"10.1007\/BF02267622"},{"key":"2022031223250228000_R19","doi-asserted-by":"crossref","unstructured":"Esler MD, Wallin G, Dorward PK, Eisenhofer G, Westerman R, Meredith I, Lambert G, Cox HS, Jennings G: Effects of desipramine on sympathetic nerve firing and norepinephrine spillover to plasma in humans. Am J Physiol\u2008260:R817\u2013R823,1991","DOI":"10.1152\/ajpregu.1991.260.4.R817"},{"key":"2022031223250228000_R20","unstructured":"Goldstein DS: Catecholamines in plasma and cerebrospinal fluid: sources and meanings. In Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States. Buckley JP, Ferrario CM, Eds. New York, Raven,1987, p.15\u201325"},{"key":"2022031223250228000_R21","doi-asserted-by":"crossref","unstructured":"Stanton Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P: Reflex sympathetic dystrophy: changing concepts and taxonomy. Pain\u200863:127\u2013133,1995","DOI":"10.1016\/0304-3959(95)00110-E"},{"key":"2022031223250228000_R22","doi-asserted-by":"crossref","unstructured":"Dyck PJ, Zimmerman IR, Johnson DM, Gillen D, Hokanson JL, Karnes JL, Gruener G, O\u2019Brien PC: A standard test of heat-pain responses using CASE IV. J Neurol Sci\u2008136:54\u201363,1996","DOI":"10.1016\/0022-510X(95)00277-9"},{"key":"2022031223250228000_R23","doi-asserted-by":"crossref","unstructured":"Dyck PJ, O\u2019Brien PC, Kosanke JL, Gillen DA, Karnes JL: A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology\u200843:1508\u20131512,1993","DOI":"10.1212\/WNL.43.8.1508"},{"key":"2022031223250228000_R24","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Cannon RO 3rd, Quyyumi A, Chang P, Duncan M, Brush JE Jr, Eisenhofer G: Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans. J Auton Nerv Syst\u200834:17\u201335,1991","DOI":"10.1016\/0165-1838(91)90005-N"},{"key":"2022031223250228000_R25","unstructured":"Goldstein DS, Coronado L, Kopin IJ: 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans. J Nucl Med\u200835:964\u2013973,1994"},{"key":"2022031223250228000_R26","doi-asserted-by":"crossref","unstructured":"Holmes C, Eisenhofer G, Goldstein DS: Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl\u2008653:131\u2013138,1994","DOI":"10.1016\/0378-4347(93)E0430-X"},{"key":"2022031223250228000_R27","doi-asserted-by":"crossref","unstructured":"Goldstein DS, Holmes C, Cannon RO III, Eisenhofer G, Kopin IJ: Sympathetic cardioneuropathy in dysautonomias. N Engl J Med\u2008336:696\u2013702,1997","DOI":"10.1056\/NEJM199703063361004"},{"key":"2022031223250228000_R28","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Goldstein DS, Kopin IJ: Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo. Clin Sci\u200876:171\u2013182,1989","DOI":"10.1042\/cs0760171"},{"key":"2022031223250228000_R29","doi-asserted-by":"crossref","unstructured":"Eisenhofer G, Rundqvist B, Friberg P: Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans. Am J Physiol\u2008274:R626\u2013R634,1998","DOI":"10.1152\/ajpregu.1998.274.3.R626"},{"key":"2022031223250228000_R30","doi-asserted-by":"crossref","unstructured":"Cubells JF, Baker H, Volpe BT, Smith GP, Das SS, Joh TH: Innervation-independent changes in the mRNAs endoding tyrosine hydroxylase and the norepinephrine transporter in rat adrenal medulla after hig-dose reserpine. Neurosci Lett\u2008193:189\u2013192,1995","DOI":"10.1016\/0304-3940(95)11699-W"},{"key":"2022031223250228000_R31","doi-asserted-by":"crossref","unstructured":"Netten PM, Wollersheim H, Thien T, Lutterman JA: Skin microcirculation of the foot in diabetic neuropathy. Clin Sci\u200891:559\u2013565,1996","DOI":"10.1042\/cs0910559"},{"key":"2022031223250228000_R32","doi-asserted-by":"crossref","unstructured":"Tooke JE: Methodologies used in the study of the microcirculation in diabetes mellitus. Diabete Metab Rev\u20089:57\u201370,1993","DOI":"10.1002\/dmr.5610090106"},{"key":"2022031223250228000_R33","doi-asserted-by":"crossref","unstructured":"Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, Lambert GW, Jennings GL, Cox HS, Seals DR: Aging effects on human sympathetic neuronal function. Am J Physiol\u2008268:R278\u2013R285,1995","DOI":"10.1152\/ajpregu.1995.268.1.R278"},{"key":"2022031223250228000_R34","doi-asserted-by":"crossref","unstructured":"Ng AV, Callister R, Johnson DG, Seals DR: Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension\u200821:498\u2013503,1993","DOI":"10.1161\/01.HYP.21.4.498"},{"key":"2022031223250228000_R35","doi-asserted-by":"crossref","unstructured":"Hetland ML, Eldrup E, Bratholm P, Christensen NJ: The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA, and neuropeptide Y-like immunoreactivity in normal human subjects. Scand J Clin Lab Invest\u200851:219\u2013224,1991","DOI":"10.3109\/00365519109091608"},{"key":"2022031223250228000_R36","doi-asserted-by":"crossref","unstructured":"Scherrer U, Owlya R, Lepori M: Body fat and sympathetic nerve activity. Cardiovasc Drugs Ther\u200810 (Suppl. 1):215\u2013222,1996","DOI":"10.1007\/BF00120490"},{"key":"2022031223250228000_R37","doi-asserted-by":"crossref","unstructured":"O\u2019Hare JA, Minaker KL, Meneilly GS, Rowe JW, Pallotta JA, Young JB: Effect of insulin on plasma norepinephrine and 3,4-dihydroxyphenylalanine in obese men. Metabolism\u200838:322\u2013329,1989","DOI":"10.1016\/0026-0495(89)90118-2"},{"key":"2022031223250228000_R38","unstructured":"Mark AL: The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens\u200814 (Suppl.):S159\u2013S165,1996"},{"key":"2022031223250228000_R39","doi-asserted-by":"crossref","unstructured":"Esler M: Sympathetic nervous system: contribution to human hypertension and related cardiovascular diseases. J Cardiovasc Pharmacol\u200826 (Suppl. 2):S24\u2013S28,1995","DOI":"10.1097\/00005344-199512020-00004"},{"key":"2022031223250228000_R40","doi-asserted-by":"crossref","unstructured":"Karlsson A, Elam M, Lo\u0308nnroth P, Sullivan L, Friberg P: Differentiated norepinephrine spillover in human skeletal muscle. Am J Physiol\u2008273:R16\u2013R21,1997","DOI":"10.1152\/ajpregu.1997.273.1.R16"},{"key":"2022031223250228000_R41","doi-asserted-by":"crossref","unstructured":"Boulton AJ, Ward JD: Diabetic neuropathies and pain. Clin Endocrinol Metab\u200815:917\u2013931,1986","DOI":"10.1016\/S0300-595X(86)80080-9"},{"key":"2022031223250228000_R42","unstructured":"Ward J: Diabetic peripheral neuropathy. In International Textbook of Diabetes Mellitus. 2nd ed. Alberti KGMM, Zimmet P, DeFronzo RA, Eds. Chichester, U.K., John Wiley & Sons,1996, p.1489\u20131490"},{"key":"2022031223250228000_R43","doi-asserted-by":"crossref","unstructured":"Britland ST, Young RJ, Sharma AK, Clarke BF: Association of painful and painless diabetic polyneuropathy with different patterns of nerve fiber degeneration and regeneration. Diabetes\u200839:898\u2013908,1990","DOI":"10.2337\/diabetes.39.8.898"},{"key":"2022031223250228000_R44","unstructured":"Joslin EP: Diabetic neuropathy. In The treatment of diabetes mellitus. 9th ed. Joslin EP, Root HF, White P, Marble A, Eds. Philadelphia, Lea & Febiger,1952, p.482\u2013483"},{"key":"2022031223250228000_R45","doi-asserted-by":"crossref","unstructured":"Ahlgren SC, Levine JD: Mechanical hyperalgesia in streptozotocin-diabetic rats is not sympathetically maintained. Brain Res\u2008616:171\u2013175,1993","DOI":"10.1016\/0006-8993(93)90206-3"},{"key":"2022031223250228000_R46","doi-asserted-by":"crossref","unstructured":"Ziegler D: Diagnosis and management of diabetic peripheral neuropathy. Diabet Med\u200813 (Suppl. 1:)S34\u2013S38,1996","DOI":"10.1002\/dme.1996.13.s1.34"},{"key":"2022031223250228000_R47","doi-asserted-by":"crossref","unstructured":"Shadiack AM, Vaccariello SA, Sun Y, Zigmond RE: Nerve growth factor inhibits sympathetic neurons\u2019 response to an injury cytokine. Proc Natl Acad Sci\u200895:7727\u20137730,1998","DOI":"10.1073\/pnas.95.13.7727"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/51\/12\/3545\/652952\/db1202003545.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/51\/12\/3545\/652952\/db1202003545.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:12:03Z","timestamp":1667405523000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/51\/12\/3545\/34290\/Local-Sympathetic-Denervation-in-Painful-Diabetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.51.12.3545","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]}}}